Bioscience Incubators Attract Big Pharma as Bristol-Myers Squibb Offers Startups Cambridge Lab Space
Bioscience Incubators Attract Big Pharma as Bristol-Myers Squibb Offers Startups Cambridge Lab Space
SUGAR LAND--March 8, 2016--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--It is an offer that simply would not have happened 10 or 20 years ago. A major player in the Pharmaceutical-Biotech Industry, in this case, Bristol-Myers Squibb (NYSE:BMS) (New York City, New York), lending a financial hand to small startup life science companies. While still incredibly competitive and proprietary, the industry has come to value nascent firms that offer promising potential to possibly beef up their product pipelines. Within this article: Shared lab space by Bristol-Myers Squibb (NYSE:BMS) and Johnson & Johnson (NYSE:JNJ).
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Beyond the Smoke Stacks: Texas Ropes in $4 Billion Pharma-Bio Investment
- Costa Rica's Alajuela Municipality Attracts Pharma Companies
- Alajuela continúa destacándose en inversiones de la industria farmacéutica ...
- Greater Houston Boasts $4 Billion in Q4 Project Kickoffs
- Great Lakes Region Leads U.S. in 4Q Manufacturing Project Starts